Endotoxin shock is associated with oxidative stress. Interaction of lipopolysaccharide (LPS) with macrophages results in the generation of oxygen derived free radicals, including hydrogen peroxide (H 2 O 2 ), superoxide anion (O 2 Ϫ ), and hydroxyl radical (OH), leading to oxidative damage in many tissues such as lung and liver.
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), and hydroxyl radical (OH), leading to oxidative damage in many tissues such as lung and liver. 1) These free radicals are involved in the pathogenesis of endotoxin shock.
2) Sensitization with D-galactosamine (D-GalN) greatly increases the sensitivity of animals to LPS and augments the lethal activity of LPS. 3) Inhibition of lipid peroxidation improves the survival rate of endotoxemic rats. 4) Various antioxidants, including pyrrolidine dithiocarbamate (PDTC) and melatonin inhibit hepatic apoptosis and subsequent liver failure and decrease lethal rates in endotoxin shock. [5] [6] [7] Protocatechuic acid (PCA) exhibits an antioxidant activity. [8] [9] [10] In the present study, the protective effects of PCA and its derivatives against murine models of sepsis were investigated.
MATERIALS AND METHODS

Animals and Reagents
Male ICR mice weighing 23-28 g, suppied by Myung-jin, Inc. (Seoul, Korea), were housed 5 per cage in a room maintained at 22Ϯ1°C with an alternating 12 h light-dark cycle. Food and water were available ad libitum. LPS (Escherichia coli 055:B5, Sigma, U.S.A.) was dissolved in phosphate-buffer saline (PBS) at 1 mg/ml and stored at Ϫ80°C until use. D-Galactosamine (GalN) (ICN, U.S.A.) was dissolved in PBS at 0.16 g/ml and added to 7.2 ml LPS solution. The LPS/GalN mixture was used immediately. Each mouse was administered LPS/GalN (LPS 36 mg/kg, GalN 0.8 g/kg) at a volume of 1 ml/100 g of body weight. PCA and its derivatives were dissolved in 10% DMSO.
LPS/GalN-Induced Lethality and Cytokine Measurements Mice were injected intraperitoneally (i.p.) with PCA and its derivatives (50 mg/kg) or vehicle at 30 min before an i.p. injection of LPS/GalN or LPS (20 mg/kg). Survival was recorded once daily for 3 d. For cytokine measurements, blood was collected at various time points (0, 1.5, 3, 6 h) after LPS/GalN administration from the retro-orbital venous plexus and centrifuged at 4000 g for 15 min at Ϫ4°C. Plasma samples were stored at Ϫ20°C until assayed. Plasma levels of tumor necrosis factor (TNF)-a, interleukin (IL)-10, and IL-6 were measured with an enzyme-linked immunoassay kit (Genzyme, U.S.A.). The sensitivity limits of TNF-a, IL-10, and IL-6 were 3 pg/ml, 13 pg/ml, and 3 pg/ml respectively. Assays were performed exactly as described by the manufacturer.
Alanine Aminotransferase and Nitrate/Nitrite Measurements Liver damage was evaluated by measuring the plasma concentration of alanine aminotransferase (ALT) using a Reitman-Frankel method GPT kit (Yeongdong Pharmaceutical Corp., Seoul, Korea). Plasma samples were diluted to 1 : 20 prior to ALT measurement. Assays were performed exactly as described by the manufacturer.
To provide an assessment of nitric oxide production, the level of nitrate/nitrite in plasma was determined using the Griess reagent. 11, 12) Briefly, plasma samples were diluted l : 7 with distilled water and incubated with assay buffer (0.3 M phosphate buffer, 0.86 mM NADPH, 0.11 mM flavinadenine dinucleotide, and 1.0 U/ml nitrate reductase) for 1 h at room temperature. Then, 100 ml of Griess reagent was added and the mixture was incubated for 15 min at room temperature. The nitrite concentrations were determined by measuring absorbance at 550 nm in an ELISA reader based on the stan- 13) Levels of MDA were measured at 1.5 h postinjection of LPS/GalN. Briefly, mice were anesthetized with ether and perfused with ice-cold saline, and the liver was quickly removed and placed on dry ice. The liver tissues were homogenized in Tris-HCl buffer, and centrifuged at 3000 g for 15 min at Ϫ4°C. Aliquots of the supernatant were stored at Ϫ20°C until assayed. MDA levels were measured using a Bioxytech LPO-568 kit (OXIS, U.S.A.). Assays were performed exactly as described by the manufacturer.
Protective Effect of Protocatechuic Acid Isopropyl Ester against Murine Models of Sepsis: Inhibition of TNF-a a and Nitric Oxide Production and Augmentation of IL-10
Statistical Analysis Survival data were analyzed by the log-rank test. All other data were evaluated by one-way analysis of variance (ANOVA). Bonferroni and NewmanKeuls tests were used for post-hoc comparisons. p values less than 0.05 were considered to indicate statistical significance.
RESULTS
Protection against LPS/GalN-Induced Lethality by PCA and PCA Isopropyl Ester To examine the protective effects of PCA and its derivatives against LPS/GalN-induced lethality, mice were pretreated with 50 mg/kg of PCA or its derivatives 30 min before LPS/GalN injection, and lethality was observed for 3 d. As shown in Table 1 , the treatment of mice with LPS/GalN induced a 100% death rate in 3 d. Intraperitoneal pretreatment of mice with PCA (50 mg/kg) reduced the death rate to 20%. Of the various PCA new derivatives, PCA n-propyl ester, PCA i-butyl ester, and PCA ipropyl ester were effective in preventing LPS/GalN-induced lethality; PCA isopropyl ester was the most effective, reducing the death rate to 0%. Therefore, we focused on PCA isopropyl ester in the subsequent experiments. Table 2 shows that PCA isopropyl ester dose-dependently protected against LPS/GalN-induced lethality, with optimal protection being achieved with 50 mg/kg. Recently, it was suggested that the LPS/GalN model may not be a good septic shock model, because it may represent a TNF-mediated hepatic necrosis model. 14) Thus, we evaluated the effect of PCA isopropyl ester on the high-dose LPS model. As shown in Table 3 , PCA isopropyl ester also effectively inhibited the high-dose LPS-induced lethality. Next, the protective effect of PCA isopropyl ester administered at different time points in relation with LPS/GalN treatment were examined. As shown in Table  4 , PCA isopropyl ester had a maximal protective effect against LPS/GalN-induced lethality when given 30 min before LPS/GalN. The efficacy of PCA isopropyl ester mostly disappeared when administered 30 min and 60 min after LPS/GalN injection.
Effect of PCA Isopropyl Ester on LPS/GalN-Induced Plasma Cytokine Levels Intraperitoneal injection of LPS/GalN into mice resulted in a marked elevation of plasma TNF-a, IL-10, and IL-6 levels at 1.5 h, which declined toward basal levels at 6 h. Pretreatment with PCA isopropyl ester (50 mg/kg, i.p.) 30 min prior to LPS/GalN injection resulted in a marked reduction of LPS/GalN-induced plasma levels of TNF-a (Fig. 1A) , accompanied by marked accentuation of plasma IL-10 levels (Fig. 1B) . In contrast, LPS/GalN-induced plasma IL-6 levels were not affected by PCA isopropyl ester (Fig. 1C) .
Protection against LPS/GalN-Induced Liver Damage LPS/GalN significantly elevated MDA concentration in liver 6 h after administration, which was significantly decreased by PCA isopropyl ester (50 mg/kg, i.p.), PCA isopropyl ester per se showed a tendency to decrease hepatic MDA levels ( Fig. 2A) . LPS/GalN markedly increased plasma ALT and nitrite/nitrate levels measured 6 h after LPS/GalN. PCA iso- propyl ester administration markedly inhibited LPS/GalN-induced plasma ALT levels ( Fig. 2B ) and nitrite/nitrate levels (Fig. 2C ).
DISCUSSION
This study shows that PCA and PCA isopropyl ester have protective effects against LPS/GalN-induced lethality in mice: the protective effect of PCA isopropyl ester was associated with inhibition of plasma levels of TNF-a and augmentation of plasma IL-10 levels.
Sepsis is associated with the induction of several cytokine species, including pro-inflammatory and anti-inflammatory mediators. The excessive production of pro-inflammatory cytokines is thought to contribute significantly to lethality. Proinflammatory TNF-a acts as an initiator in the cascade of endogenous mediators that will direct the inflammatory and metabolic responses eventually leading to severe shock and organ failure. 15) On the other hand, anti-inflammatory cytokine IL-10 is a potent inhibitor of the functions of monocytes/macrophages, including oxidative burst, nitric oxide production and production of pro-inflammatory cytokines, such as TNF-a, IL-1b, IL-12 and INF-g. [16] [17] [18] Recombinant IL-10 potently suppresses LPS-induced production of TNFa, and pretreatment with IL-10 inhibits TNF-a activity and prevents LPS-induced mortality in mice. [19] [20] [21] Therefore, inhibition of TNF-a levels and augmentation of IL-10 levels can be a quite effective way for treating or preventing septic shock. In this respect, the action of PCA isopropyl ester could be ideal for this purpose.
LPS/GalN-induced hepatic injury is caused by hepatocyte apoptosis mediated mainly by TNF-a through the p55 receptor. 22, 23) TNF-a may be primarily responsible for hepatic injury and TNF-a-induced NO release after LPS injection may participate in the development of hepatic injury. 24) Our results show that PCA isopropyl ester reduced LPS/GalN-induced TNF-a and NO production, which may be involved in the protection against liver damage, as demonstrated by the reduction of hepatic MDA and plasma ALP levels.
LPS directly inhibits lipid metabolism, causes hepatotoxicity and lipid peroxidation via the induction of free radicals. 25) Various antioxidants, including PDTC, and melatonin, sup- press TNF-a release, block hepatic apoptosis and subsequent liver failure, and decrease lethality rates in endotoxin shock models. 26, 27) Furthermore, PCA was shown to inhibit inducible nitric oxide syntheses and hepatic damage by LPS. 28) The result that PCA isopropyl ester significantly decreased LPS-induced hepatic lipid peroxidation suggests that some of the beneficial effects of PCA isopropyl ester may be due to its antioxidant properties.
In summary, inhibition of TNF-a and nitric oxide production and lipid peroxidation and augmentation of IL-10 induced by PCA isopropyl ester would make it effective in protection against sepsis. Further study on the structure-activity relationship of PCA derivatives is needed.
